-
Signature
-
/s/ Christopher Hilberg, Attorney-in-Fact
-
Issuer symbol
-
SKYT
-
Transactions as of
-
08 Aug 2025
-
Transactions value $
-
-$100,824
-
Form type
-
4
-
Filing time
-
12 Aug 2025, 17:03:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Manko Steve |
CFO |
2401 EAST 86TH STREET, BLOOMINGTON |
/s/ Christopher Hilberg, Attorney-in-Fact |
12 Aug 2025 |
0001856680 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SKYT |
Common Stock |
Options Exercise |
$98.4K |
+9.71K |
+2.63% |
$10.14 |
378K |
08 Aug 2025 |
Direct |
F1 |
| transaction |
SKYT |
Common Stock |
Options Exercise |
$316K |
+28.1K |
+7.44% |
$11.24 |
406K |
08 Aug 2025 |
Direct |
F1 |
| transaction |
SKYT |
Common Stock |
Sale |
-$516K |
-37.8K |
-9.32% |
$13.62 |
368K |
08 Aug 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SKYT |
Options to Acquire Common Stock |
Options Exercise |
$0 |
-28.1K |
-63.96% |
$0.00 |
15.9K |
08 Aug 2025 |
Common Stock |
28.1K |
$11.24 |
Direct |
F1, F3 |
| transaction |
SKYT |
Options to Acquire Common Stock |
Options Exercise |
$0 |
-9.71K |
-25% |
$0.00 |
29.1K |
08 Aug 2025 |
Common Stock |
9.71K |
$10.14 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: